ASTA Follows Up with FDA on Saffron Holds and Rejections

ASTA met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.

Membership Required

A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.

Log in

Not a member yet? Click here to learn about joining ASTA today.

Related Resources

2025 Annual Report Now Available

News & Updates Industry News

3/11/2025

Check out ASTA's 2025 Annual Report which provides an annual summary of ASTA's work and progress, including financial statements as well as governance information.